A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign.
Identifieur interne : 000554 ( Main/Corpus ); précédent : 000553; suivant : 000555A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign.
Auteurs : Eve Dubé ; Defay Fannie ; Gilca Vladimir ; Bettinger A. Julie ; Sauvageau Chantal ; Lavoie France ; Boucher D. François ; Mcneil Shelly ; Gemmill Ian ; Boulianne NicoleSource :
- BMC public health [ 1471-2458 ] ; 2011.
English descriptors
- KwdEn :
- Adolescent, Canada (epidemiology), Child, Child, Preschool, Clinical Competence, Disease Outbreaks (prevention & control), Female, Health Care Surveys, Humans, Immunization Programs (statistics & numerical data), Infant, Influenza A Virus, H1N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza, Human (epidemiology), Influenza, Human (immunology), Influenza, Human (prevention & control), Male, Pediatrics, Physicians.
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- epidemiology : Canada, Influenza, Human.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza Vaccines, Influenza, Human.
- prevention & control : Disease Outbreaks, Influenza, Human.
- statistics & numerical data : Immunization Programs.
- Adolescent, Child, Child, Preschool, Clinical Competence, Female, Health Care Surveys, Humans, Infant, Male, Pediatrics, Physicians.
Abstract
BACKGROUND
In June 2009, the World Health Organization declared an A(H1N1) influenza pandemic. In October 2009, the largest vaccination campaign in Canadian history began. The aim of this study was to document paediatricians' knowledge, attitudes and practices (KAP) regarding A(H1N1) pandemic influenza and its prevention by vaccination just after the beginning of the A(H1N1) vaccination campaign and to compare the results with those obtained before campaign initiation.
METHODS
A self-administered mail-based questionnaire was sent to all Canadian paediatricians. Questionnaires were analyzed in two subsets: those received before and after the beginning of the vaccination campaign.
RESULTS
Overall the response rate was 50%. Respondents' characteristics were comparable between the two subsets. Before the beginning of the campaign, 63% of paediatricians perceived A(H1N1) pandemic infection as a serious disease, that would occur frequently without vaccination compared to more than 75% after. Before the vaccination campaign, half of respondents or less thought that the A(H1N1) vaccine was safe (50%) and effective (35%) compared to 77% and 72% after. The proportion of paediatricians who reported they had received sufficient information on A(H1N1) vaccine increased from 31% before to 73% after the beginning of the vaccination campaign. The majority of respondents intended to get vaccinated against A(H1N1) influenza themselves (84% before and 92% after). Respondents' intention to recommend the A(H1N1) vaccine to their patients increased from 80% before the beginning of the campaign to 92% after. In multivariate analysis, the main determinants of paediatricians' intention to recommend the A(H1N1) vaccine were their intention to get vaccinated against A(H1N1) influenza themselves and a belief that A(H1N1) vaccine would be well accepted by health professionals who administer vaccines to the public.
CONCLUSION
Results of this study show important increases in physicians' level of confidence about A(H1N1) vaccine's safety and immunogenicity and their willingness to recommend this vaccine to their patients. These changes could be explained, at least partially, by the important effort done by public health authorities to disseminate information regarding A(H1N1) vaccination.
DOI: 10.1186/1471-2458-11-128
PubMed: 21342511
Links to Exploration step
pubmed:21342511Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign.</title><author><name sortKey="Dube, Eve" sort="Dube, Eve" uniqKey="Dube E" first="Eve" last="Dubé">Eve Dubé</name><affiliation><nlm:affiliation>Institut National de Santé publique du Québec, 2400 d'Estimauville, Québec, Canada. eve.dube@ssss.gouv.qc.ca.</nlm:affiliation></affiliation></author><author><name sortKey="Fannie, Defay" sort="Fannie, Defay" uniqKey="Fannie D" first="Defay" last="Fannie">Defay Fannie</name></author><author><name sortKey="Vladimir, Gilca" sort="Vladimir, Gilca" uniqKey="Vladimir G" first="Gilca" last="Vladimir">Gilca Vladimir</name></author><author><name sortKey="Julie, Bettinger A" sort="Julie, Bettinger A" uniqKey="Julie B" first="Bettinger A" last="Julie">Bettinger A. Julie</name></author><author><name sortKey="Chantal, Sauvageau" sort="Chantal, Sauvageau" uniqKey="Chantal S" first="Sauvageau" last="Chantal">Sauvageau Chantal</name></author><author><name sortKey="France, Lavoie" sort="France, Lavoie" uniqKey="France L" first="Lavoie" last="France">Lavoie France</name></author><author><name sortKey="Francois, Boucher D" sort="Francois, Boucher D" uniqKey="Francois B" first="Boucher D" last="François">Boucher D. François</name></author><author><name sortKey="Shelly, Mcneil" sort="Shelly, Mcneil" uniqKey="Shelly M" first="Mcneil" last="Shelly">Mcneil Shelly</name></author><author><name sortKey="Ian, Gemmill" sort="Ian, Gemmill" uniqKey="Ian G" first="Gemmill" last="Ian">Gemmill Ian</name></author><author><name sortKey="Nicole, Boulianne" sort="Nicole, Boulianne" uniqKey="Nicole B" first="Boulianne" last="Nicole">Boulianne Nicole</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21342511</idno><idno type="pmid">21342511</idno><idno type="doi">10.1186/1471-2458-11-128</idno><idno type="wicri:Area/Main/Corpus">000554</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000554</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign.</title><author><name sortKey="Dube, Eve" sort="Dube, Eve" uniqKey="Dube E" first="Eve" last="Dubé">Eve Dubé</name><affiliation><nlm:affiliation>Institut National de Santé publique du Québec, 2400 d'Estimauville, Québec, Canada. eve.dube@ssss.gouv.qc.ca.</nlm:affiliation></affiliation></author><author><name sortKey="Fannie, Defay" sort="Fannie, Defay" uniqKey="Fannie D" first="Defay" last="Fannie">Defay Fannie</name></author><author><name sortKey="Vladimir, Gilca" sort="Vladimir, Gilca" uniqKey="Vladimir G" first="Gilca" last="Vladimir">Gilca Vladimir</name></author><author><name sortKey="Julie, Bettinger A" sort="Julie, Bettinger A" uniqKey="Julie B" first="Bettinger A" last="Julie">Bettinger A. Julie</name></author><author><name sortKey="Chantal, Sauvageau" sort="Chantal, Sauvageau" uniqKey="Chantal S" first="Sauvageau" last="Chantal">Sauvageau Chantal</name></author><author><name sortKey="France, Lavoie" sort="France, Lavoie" uniqKey="France L" first="Lavoie" last="France">Lavoie France</name></author><author><name sortKey="Francois, Boucher D" sort="Francois, Boucher D" uniqKey="Francois B" first="Boucher D" last="François">Boucher D. François</name></author><author><name sortKey="Shelly, Mcneil" sort="Shelly, Mcneil" uniqKey="Shelly M" first="Mcneil" last="Shelly">Mcneil Shelly</name></author><author><name sortKey="Ian, Gemmill" sort="Ian, Gemmill" uniqKey="Ian G" first="Gemmill" last="Ian">Gemmill Ian</name></author><author><name sortKey="Nicole, Boulianne" sort="Nicole, Boulianne" uniqKey="Nicole B" first="Boulianne" last="Nicole">Boulianne Nicole</name></author></analytic><series><title level="j">BMC public health</title><idno type="eISSN">1471-2458</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Canada (epidemiology)</term><term>Child</term><term>Child, Preschool</term><term>Clinical Competence</term><term>Disease Outbreaks (prevention & control)</term><term>Female</term><term>Health Care Surveys</term><term>Humans</term><term>Immunization Programs (statistics & numerical data)</term><term>Infant</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (prevention & control)</term><term>Male</term><term>Pediatrics</term><term>Physicians</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Canada</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza Vaccines</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Immunization Programs</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Child</term><term>Child, Preschool</term><term>Clinical Competence</term><term>Female</term><term>Health Care Surveys</term><term>Humans</term><term>Infant</term><term>Male</term><term>Pediatrics</term><term>Physicians</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>In June 2009, the World Health Organization declared an A(H1N1) influenza pandemic. In October 2009, the largest vaccination campaign in Canadian history began. The aim of this study was to document paediatricians' knowledge, attitudes and practices (KAP) regarding A(H1N1) pandemic influenza and its prevention by vaccination just after the beginning of the A(H1N1) vaccination campaign and to compare the results with those obtained before campaign initiation.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>A self-administered mail-based questionnaire was sent to all Canadian paediatricians. Questionnaires were analyzed in two subsets: those received before and after the beginning of the vaccination campaign.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Overall the response rate was 50%. Respondents' characteristics were comparable between the two subsets. Before the beginning of the campaign, 63% of paediatricians perceived A(H1N1) pandemic infection as a serious disease, that would occur frequently without vaccination compared to more than 75% after. Before the vaccination campaign, half of respondents or less thought that the A(H1N1) vaccine was safe (50%) and effective (35%) compared to 77% and 72% after. The proportion of paediatricians who reported they had received sufficient information on A(H1N1) vaccine increased from 31% before to 73% after the beginning of the vaccination campaign. The majority of respondents intended to get vaccinated against A(H1N1) influenza themselves (84% before and 92% after). Respondents' intention to recommend the A(H1N1) vaccine to their patients increased from 80% before the beginning of the campaign to 92% after. In multivariate analysis, the main determinants of paediatricians' intention to recommend the A(H1N1) vaccine were their intention to get vaccinated against A(H1N1) influenza themselves and a belief that A(H1N1) vaccine would be well accepted by health professionals who administer vaccines to the public.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>Results of this study show important increases in physicians' level of confidence about A(H1N1) vaccine's safety and immunogenicity and their willingness to recommend this vaccine to their patients. These changes could be explained, at least partially, by the important effort done by public health authorities to disseminate information regarding A(H1N1) vaccination.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21342511</PMID><DateCompleted><Year>2011</Year><Month>06</Month><Day>30</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2011</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign.</ArticleTitle><Pagination><MedlinePgn>128</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1471-2458-11-128</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In June 2009, the World Health Organization declared an A(H1N1) influenza pandemic. In October 2009, the largest vaccination campaign in Canadian history began. The aim of this study was to document paediatricians' knowledge, attitudes and practices (KAP) regarding A(H1N1) pandemic influenza and its prevention by vaccination just after the beginning of the A(H1N1) vaccination campaign and to compare the results with those obtained before campaign initiation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A self-administered mail-based questionnaire was sent to all Canadian paediatricians. Questionnaires were analyzed in two subsets: those received before and after the beginning of the vaccination campaign.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall the response rate was 50%. Respondents' characteristics were comparable between the two subsets. Before the beginning of the campaign, 63% of paediatricians perceived A(H1N1) pandemic infection as a serious disease, that would occur frequently without vaccination compared to more than 75% after. Before the vaccination campaign, half of respondents or less thought that the A(H1N1) vaccine was safe (50%) and effective (35%) compared to 77% and 72% after. The proportion of paediatricians who reported they had received sufficient information on A(H1N1) vaccine increased from 31% before to 73% after the beginning of the vaccination campaign. The majority of respondents intended to get vaccinated against A(H1N1) influenza themselves (84% before and 92% after). Respondents' intention to recommend the A(H1N1) vaccine to their patients increased from 80% before the beginning of the campaign to 92% after. In multivariate analysis, the main determinants of paediatricians' intention to recommend the A(H1N1) vaccine were their intention to get vaccinated against A(H1N1) influenza themselves and a belief that A(H1N1) vaccine would be well accepted by health professionals who administer vaccines to the public.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Results of this study show important increases in physicians' level of confidence about A(H1N1) vaccine's safety and immunogenicity and their willingness to recommend this vaccine to their patients. These changes could be explained, at least partially, by the important effort done by public health authorities to disseminate information regarding A(H1N1) vaccination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dubé</LastName><ForeName>Eve</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institut National de Santé publique du Québec, 2400 d'Estimauville, Québec, Canada. eve.dube@ssss.gouv.qc.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fannie</LastName><ForeName>Defay</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Vladimir</LastName><ForeName>Gilca</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Julie</LastName><ForeName>Bettinger A</ForeName><Initials>BA</Initials></Author><Author ValidYN="Y"><LastName>Chantal</LastName><ForeName>Sauvageau</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>France</LastName><ForeName>Lavoie</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>François</LastName><ForeName>Boucher D</ForeName><Initials>BD</Initials></Author><Author ValidYN="Y"><LastName>Shelly</LastName><ForeName>McNeil</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ian</LastName><ForeName>Gemmill</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Nicole</LastName><ForeName>Boulianne</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N">Canada</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002983" MajorTopicYN="Y">Clinical Competence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010372" MajorTopicYN="N">Pediatrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010820" MajorTopicYN="Y">Physicians</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>10</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>02</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21342511</ArticleId><ArticleId IdType="pii">1471-2458-11-128</ArticleId><ArticleId IdType="doi">10.1186/1471-2458-11-128</ArticleId><ArticleId IdType="pmc">PMC3050752</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vaccine. 2010 Oct 18;28(44):7207-14</Citation><ArticleIdList><ArticleId IdType="pubmed">20804802</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pediatr (Phila). 2003 Sep;42(7):635-40</Citation><ArticleIdList><ArticleId IdType="pubmed">14552523</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2005 Mar 31;23(19):2470-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15752833</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2001 Dec 10-24;161(22):2702-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11732935</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 1997 Feb;99(2):209-15</Citation><ArticleIdList><ArticleId IdType="pubmed">9024448</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2005 Jun;115(6):1479-87</Citation><ArticleIdList><ArticleId IdType="pubmed">15930207</ArticleId></ArticleIdList></Reference><Reference><Citation>CJEM. 2005 Jan;7(1):17-21</Citation><ArticleIdList><ArticleId IdType="pubmed">17355649</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2005 Nov;116(5):e623-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16263976</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2007 Nov 7;25(45):7841-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17923173</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Aug 9;28(35):5703-10</Citation><ArticleIdList><ArticleId IdType="pubmed">20600497</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 1994 Oct;94(4 Pt 1):517-23</Citation><ArticleIdList><ArticleId IdType="pubmed">7936863</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2009 Feb 18;27(8):1242-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19114078</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Med Res. 2009 Nov;40(8):705-11</Citation><ArticleIdList><ArticleId IdType="pubmed">20304260</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Feb 15;50(4):523-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20064038</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immune Based Ther Vaccines. 2003 Nov 5;1(1):3</Citation><ArticleIdList><ArticleId IdType="pubmed">14613575</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2009 Jun 19;27(30):3935-44</Citation><ArticleIdList><ArticleId IdType="pubmed">19467744</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2001 May 15;164(10):1413-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11387913</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Infect Control. 2009 Sep;37(7):551-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19556035</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Health Serv Res. 2009;9:30</Citation><ArticleIdList><ArticleId IdType="pubmed">19216792</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 2009 Oct;99 Suppl 2:S248-54</Citation><ArticleIdList><ArticleId IdType="pubmed">19461110</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Fam Physician. 2010 Feb;56(2):157-63</Citation><ArticleIdList><ArticleId IdType="pubmed">20154251</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med. 2007;5:11</Citation><ArticleIdList><ArticleId IdType="pubmed">17535430</ArticleId></ArticleIdList></Reference><Reference><Citation>Infection. 2006 Jun;34(3):142-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16804657</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Res Notes. 2010 Apr 14;3:102</Citation><ArticleIdList><ArticleId IdType="pubmed">20398265</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2009 Dec 10;28(1):207-27</Citation><ArticleIdList><ArticleId IdType="pubmed">19800997</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009;339:b3391</Citation><ArticleIdList><ArticleId IdType="pubmed">19706937</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Mar 24;28(15):2743-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20117271</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2009 Sep 25;27(42):5732-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19679219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2005 Apr;11(4 Suppl):S20-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15812485</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000554 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000554 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:21342511
|texte= A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:21342511" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |